Patents by Inventor Soren Germer

Soren Germer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Single Nucleotide Polymorphisms That Predict HCV Treatment Outcomes
    Publication number: 20120094389
    Abstract: The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 4 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.
    Type: Application
    Filed: April 11, 2011
    Publication date: April 19, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Uri Lopatin, Tom Chu, Laurent Essioux, Soren Germer, Nancy Shulman, James A. Thommes
  • Prediction of Early Virological Response in HCV Treatment
    Publication number: 20120094284
    Abstract: The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.
    Type: Application
    Filed: April 11, 2011
    Publication date: April 19, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Uri Lopatin, Tom Chu, Laurent Essioux, Soren Germer, Nancy Shulman, James A. Thommes
  • POLYMORPHISM MARKERS FOR PREDICTING RESPONSE TO INTERLEUKIN-6 RECEPTOR-INHIBITING MONOCLONAL ANTIBODY DRUG TREATMENT
    Publication number: 20110262462
    Abstract: The present invention provides single nucleotide polymorphisms (SNPs) associated with clinical responsiveness of rheumatoid arthritis patients to treatment with an interleukin-6 receptor antibody such as tocilizumab, and methods of using such SNPs for predicting clinical response to treatment with the antibody.
    Type: Application
    Filed: April 15, 2011
    Publication date: October 27, 2011
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Adam Platt, Laurent Essioux, Mitchell Martin, Soren Germer, Jianmei Wang
  • Single Nucelotide Polymorphism (SNP)
    Publication number: 20090130660
    Abstract: Association of Type 2 diabetes with single nucleotide polymorphisms and haplotypes are disclosed. Also disclosed are diagnostic applications in identifying those who have Type 2 diabetes or are at risk of developing Type 2 diabetes, and discovery of therapeutic agents and methods of treatment.
    Type: Application
    Filed: December 5, 2005
    Publication date: May 21, 2009
    Inventors: Malek Faham, Soren Germer, Hywel Bowden Jones, Delphine Lagarde, Mitchell Lee Martin, Martin Emilio Moorhead, Erik Roy Rasmussen, Brian Kent Rhees, James Andrew Rosinski
  • Methods of genotyping using differences in melting temperature
    Publication number: 20060172324
    Abstract: The present invention relates to the identification of a particular nucleotide polymorphism in a nucleic acid sample in a single reaction utilizing oligonucleotide primers with different melting temperature characteristics.
    Type: Application
    Filed: December 8, 2005
    Publication date: August 3, 2006
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Jun Wang, Daniel Mirel, Soren Germer, Russell Higuchi